Bortezomib

Kamimura T, et al. High incidence and severity of injection site reactions in the first cycle compared with subsequent cycles of subcutaneous bortezomib. International Journal of Hematology 98: 694-701, No. 6, Dec 2013. Available from: URL: http://doi.org/10.1007/s12185-013-1469-7 - JapanPubMedCrossRefGoogle Scholar